Evidence map›Paper›PMID 36381164›Full record

ArticleCentral European journal of urology2022

Active surveillance for low-risk prostate cancer: well established, yet avoided?

Roman Sosnowski, Hubert Kamecki, Jakub Dobruch, Monique J Roobol, Lionne D F Venderbos, Łukasz Nyk, Wojciech Krajewski, Tomasz Drewa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Central European journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roman SosnowskiDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Hubert Kamecki2 Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Jakub DobruchDepartment of Urology, Center of Postgraduate Medical Education, Warsaw, Poland.
Monique J RoobolDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Lionne D F VenderbosDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Łukasz Nyk2 Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Wojciech KrajewskiDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland.
Tomasz DrewaDepartment of General and Oncologic Urology, Nicolaus Copernicus Hospital, Toruń, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active surveillancebarrierslow-riskprostate cancer

Identifiers

PMID36381164
PMCPMC9628721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.